This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Armistead M. Lee

JAMA. 1975;234(12):1242-1244.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IT IS AN occupational hazard of advocates to overstate the size of the problems their innovations might correct and the benefits of their proposed solutions. The average physician makes due allowance for such possible bias when listening to a pharmaceutical company's sales representative. However, he may not be equally aware of the same potential for bias when listening to the advocate of some new proposal for "upgrading" the quality and rationality of health care.

One such advocate is T. Donald Rucker, PhD. In an article¹ in THE JOURNAL, Dr. Rucker proposed a computerized drug information system that would provide, among other benefits, a means for ongoing peer review of medications prescribed.

To oppose utilization review in any form is equivalent to attacking motherhood. It is an idea that has been widely accepted in principle and applied in practice for many years, as any member of a hospital tissue committee . . . [Full Text PDF of this Article]

Author Affiliations
From the Pharmaceutical Manufacturers Association, Washington, DC.

Footnotes
Reprints are not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?